Aseptic Technologies

Aseptic Technologies, founded in 2003 and based in Gembloux, Belgium, is a specialized provider of aseptic processing solutions for the life sciences industry, particularly for advanced therapies like cell and gene therapies. Its core technology platform centers on the AT-Closed Vial® system and robotic aseptic filling lines, which are designed to de-risk manufacturing processes and ensure container closure integrity, even under cryogenic conditions. As a private company within the SKAN Group, it operates a business-to-business (B2B) services and manufacturing model, generating revenue by selling equipment, consumables, and custom device manufacturing services to pharmaceutical and medtech clients. The company is positioned at a critical juncture in biomanufacturing, where the scalability and reliability of aseptic fill-finish are paramount for the commercialization of novel therapies.

AT-Closed Vial® system for container closure integrity and robotic aseptic filling lines for sterile drug product manufacturing, with expertise in clean injection molding for custom devices.

Competes with large capital equipment firms like Syntegon and IMA in the fill-finish space, as well as other specialized vial and closure system providers. Differentiation is achieved through deep specialization in advanced therapies, the proprietary AT-Closed Vial®, and integration with SKAN's isolator expertise.